Real-world outcomes among US Merkel cell carcinoma patients initiating immune checkpoint inhibitors or chemotherapy.
暂无分享,去创建一个
S. Chandra | R. Kim | H. Phatak | Ying Zheng | M. Kearney | Ting Yu | S. Pandya | Li Wang
暂无分享,去创建一个
S. Chandra | R. Kim | H. Phatak | Ying Zheng | M. Kearney | Ting Yu | S. Pandya | Li Wang